Newsylist real-time news trend intelligence
↓ Cooling Business

FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly

The FDA has granted clearance to a new Alzheimer’s disease blood test developed by Roche and Eli Lilly.

10sources
10articles
11velocity
-21%since first seen
4h agofirst detected

Who reported it (10)

The brief

One first-of-its-kind biomarker blood test developed jointly by Roche and Eli Lilly has officially secured clearance from the Food and Drug Administration. The regulatory decision applies to the Roche Elecsys pTau217 test and covers use for Americans as young as 40, functioning to aid in rule-in and rule-out assessments for Alzheimer's disease evaluation.

Future availability, clinical rollout timelines, and pricing details have not yet been specified in available reports.

Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (75% supported) Updated 1h ago.

Quick answers

Who developed the newly cleared Alzheimer's blood test?

The test was developed by Roche and Eli Lilly.

What is the name of the approved test according to reports?

Coverage identifies it as the Roche Elecsys pTau217 test.

What age group does the clearance apply to?

Reports indicate the test is cleared for Americans as young as 40.

Momentum

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

3423110Aug 24 15:29Aug 24 18:29 UTC

People, places & organizations

Topics

Related trends